PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

• R Zhang,
• C Stanley,
• X Hu,
• V Chow,
• N Tchao,
• R Furie,
• N Sarkar,
• C Milmont,
• Y Shi Jin,
• M Kroenke,
• K Gorski,
• K Alan

Affiliations

R Zhang

1Section of Nephrology

C Stanley

Emergency Department, South Manchester University Hospital, Wythenshawe, UK

X Hu

Jiangsu Provincial Center for Public Health and Disease Control, China CDC, Nanjing, PR China

V Chow

Department of Cardiology, Concord Hospital, The University of Sydney, Sydney, New South Wales, Australia

N Tchao

1Amgen Inc., Department of Early Development, South San Francisco, USA

R Furie

4Hofstra North Shore-LIJ School of Medicine, Rheumatology, Great Neck, USA

N Sarkar

1Amgen Inc ~ South San Francisco ~ USA

C Milmont

2Amgen Inc ~ Thousand Oaks ~ USA

Y Shi Jin

2Amgen Inc ~ Thousand Oaks ~ USA

M Kroenke

2Amgen Inc ~ Thousand Oaks ~ USA

K Gorski

1Amgen Inc ~ South San Francisco ~ USA

K Alan

4Altoona Center for Clinical Research ~ Duncansville ~ USA